Showing results (41-50 of 79) with videos related to
Sort By:
Pageof 8
Oncoimmunology|April 21, 2026
Spatial transcriptomics unveils immune cellular ecosystems associated with patient survival in diffuse large B-cell lymphomaAlba Diaz-Herrero, Héctor Fernando Pelaez-Prestel, Lucile Massenet-Regad, et al.Bulletin Du Cancer|January 23, 2015
Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancerJeanne Netter, Jacqueline Lehmann-Che, Jerome Lambert, et al.International Journal of Cancer|August 14, 2012
Distinct tumor protein p53 mutants in breast cancer subgroupsAnne Dumay, Jean-Paul Feugeas, Evelyne Wittmer, et al.Nature Communications|May 26, 2018
Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemiaJacqueline Lehmann-Che, Cécile Bally, Eric Letouzé, et al.Cancer|March 19, 2013
Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapyDavid Groheux, Mathieu Hatt, Elif Hindié, et al.European Urology Oncology|June 1, 2024
Circulating Biomarkers Predictive of Treatment Response in Patients with Hormone-sensitive or Castration-resistant Metastatic Prostate Cancer: A Systematic ReviewMichael Baboudjian, Arthur Peyrottes, Charles Dariane, et al.Annales De Pathologie|September 19, 2016
[Backstage of a massive open online course (MOOC) on cancer diagnosis]Charlotte Gardair, Guilhem Bousquet, Jacqueline Lehmann-Che, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 4, 2023
Assessment of the reliability of MSI status and dMMR proteins deficiency screening on endoscopic biopsy material in esophagus and gastric adenocarcinomaNicolas Asesio, Nozha Mhamdi Aloui, Julie Bonnereau, et al.Anticancer Research|May 2, 2018
First French Pilot Quality Assessment of the EndoPredict Test for Early Luminal Breast CarcinomaJacqueline Lehmann-Che, Catherine Miquel, Jennifer Wong, et al.The Oncologist|March 16, 2010
Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancersJacqueline Lehmann-Che, Fabrice André, Christine Desmedt, et al.Pageof 8